While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...

AstraZeneca has announced a $2bn investment plan to expand its biomanufacturing presence in Frederick, Maryland, US.

Lilly breaking through the $1tn market cap ceiling comes as investors have increasingly turned to pharma stocks. The S&P 500 ...

OSR Company Vaximm has linked with investor BCM Europe (BCME) for a potential exclusive worldwide licence for Vaximm’s VXM01.

The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in ...

In 2024, the FDA granted a record 63 designations to antibody drug conjugates (ADCs), nearly double the previous high of 35 ...

Advances in large-volume injectors are enabling faster, more comfortable, at-home treatment. Patient-centric design, ...

Roche has received conditional marketing authorisation from the European Commission (EC) for Lunsumio (mosunetuzumab) ...

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by Texas Attorney General Ken Paxton that they ...

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.